Becton, Dickinson & Aktie News

NEW YORK, NY / ACCESSWIRE / April 18, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE: BDX). The settlement provides for a fund of $85,000,000 to benefit class members.

NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE: BDX). The settlement provides for a fund of $85,000,000 to benefit class members.

NEW YORK, NY / ACCESSWIRE / April 11, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX). The settlement provides for a fund of $85,000,000 to benefit class members.

NEW YORK, NY / ACCESSWIRE / April 9, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX). The settlement provides for a fund of $85,000,000 to benefit class members.

FRANKLIN LAKES, N.J. , April 9, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives.

New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of Discovery FRANKLIN LAKES, N.J. , April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biolog...

FRANKLIN LAKES, N.J. , April 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024.

NEW YORK, NY / ACCESSWIRE / April 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX). The settlement provides for a fund of $85,000,000 to benefit class members.